Hematopoietic growth factors and transfusion medicine

G. Ramsey*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

At least 20 different hematopoietic drugs (see Table 1) are currently under investigation. These most likely will impact on all aspects of transfusion therapy. Which agents to use and in what combinations will be the subject of scrutiny for many years to come as scientists try to recreate and enhance the process of hematopoiesis. Perhaps someday blood cells and hematopoietic progenitor cells can be manufactured for therapy with genetically selected phenotypes to avoid immune destruction and rejection. If this comes to pass, blood donations as we know them today, as a valuable adjunct to medical care, will fade into history, supplanted by the use of hematopoietic growth factors.

Original languageEnglish (US)
Pages (from-to)195-205
Number of pages11
JournalTransfusion Medicine Reviews
Volume12
Issue number3
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of 'Hematopoietic growth factors and transfusion medicine'. Together they form a unique fingerprint.

Cite this